Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Opinion

Pharmacy clawbacks are a perverse windfall tax

With the outcome of England's community pharmacy contract still up in the air, let's hope the government doesn't decide to impose another clawback on an already beleaguered sector, says Andrew Lane

Businesses Contracts

Statistical nonsense: Don’t read too much into GPhC exam pass rate data

Digging down into the General Pharmaceutical Council (GPhC) exam pass rate data without the right context isn’t helpful – and can be downright damaging, warns Khalid Khan

People Academics

Workforce planning must recognise pharmacy's place in the NHS family

When will the government stop treating community pharmacy like the NHS’s poor relation, asks NPA vice chair Nick Kaye

Businesses General Business

Off their trolley: Has Tesco Pharmacy pushed the locum rate row to new highs?

Reports that the supermarket chain is threatening locums with cancelled shifts if they do not agree to lower pay show the nasty side of the rate debate, says C+D editor Beth Kennedy

Businesses General Business

NI pharmacy chief: ‘We’ve re-established dialogue with politicians at a key time for the sector’

Community Pharmacy Northern Ireland (CPNI) chief Gerard Greene hails the importance of the sector being able to once again connect directly with elected political representatives in the country.  

Businesses People

The GPhC and the curse of the high stakes examination – why now is time for change

While watching the fallout from the latest GPhC exam “issues”, Gareth Nickless has some thoughts on how and why the registration assessment should change

People Academics

‘Javid’s pharmacy reforms should start with healing the great divide with GPs’

If Sajid Javid is going to reform primary care pharmacy, he will first need to heal the great divide between GP and community, writes The GP Pharmacist

Businesses People

‘Perhaps trust is pharmacy’s real prize with the cancer diagnosis pilot’

I welcome the trust that the community pharmacy cancer diagnosis pilot implies might be coming our way, but let’s hope the service is designed for us to be able to nail it, The Area Manager says

Oncology Services

GP view: Pharmacy cancer scan plan leaves more questions than it answers

A pilot allowing pharmacists to spot signs of cancer sounds great on the surface, but piling yet more work onto a profession already at breaking point seems unwise, says Toni Hazell

Services Oncology

How can pharmacists support people with menopause symptoms?

As hormone replacement therapy (HRT) shortages thrust women’s health into the mainstream conversation, pharmacy teams can expect to face many more patient queries. Here are six ways pharmacists can support those with menopause symptoms

Services Products

‘Pharmacy should be given a fighting chance in the current broken primary care system’

As the long-awaited Fuller stocktake is published, Leyla Hannbeck reflects on the missed opportunity to put pharmacy at the frontline of prevention and questions the real reasons the sector has once again been overlooked

People Pharmacy organisations

Xrayser: I'm no longer an angry young pharmacy owner – it's time to pass on the pen

As the contractor behind C+D’s anonymous column Xrayser puts down his pen for the last time, he reflects on over a decade of satirising current events in community pharmacy – and offers some words of advice for his successor

Businesses Contracts
See All
UsernamePublicRestriction

Register